312 New Highly Skilled Jobs Coming To Lansdale As Pharma Company Expands

LANSDALE, PA -- A Montgomery County company is expanding its operations in Souderton and Lansdale, bringing 312 new jobs to the area over the next three years, Governor Wolf's office has announced.

Almac Group, a global contract pharmaceutical development and manufacturing organization, will expand its Souderton operations while adding a new office space in Lansdale.

“In 2007, Almac Group invested $100 million, retained 495 jobs, and created another 264 jobs, when it successfully established its U.S. headquarters in Pennsylvania,” said Governor Wolf. “Since then, we’ve seen Almac Group’s significant contributions to the economic vitality of the region as a major player in southeastern Pennsylvania’s strong bio-pharma industry, and we look forward to its continued success as it once again chooses Pennsylvania for its operations expansion.”

The Governor's Action Team, an experienced group of economic development professionals who report directly to the governor, was crucial in facilitating the expansion. Almac Group received a funding proposal from the Department of Community and Economic Development comprised of a $1.56 million Pennsylvania First Program grant, the state said.

The new Lansdale office space will be 26,000 square feet.

“Due to significant industry demand for our services, it is essential we build capacity and increase headcount to ensure we continue to compete at a global level. This year we are celebrating our 20th year in the US, and having experienced tremendous success we are excited to make a further commitment within the Montgomery County area,” said Almac Group CEO Alan Armstrong. “This investment signifies our confidence in the pool of talent and skills right on our doorstep. We truly appreciate the guidance and support provided by both the Governor’s Action Team and the Department of Community and Economic Development throughout this entire process and look forward to a very exciting future together.”

Almac's services include research and development, biomarker discovery, development and commercialization, active pharmaceutical ingredients manufacture, formulation development, and clinical trial supply. Almac Group employs more than 4,500 personnel throughout its operations in the UK, Ireland, the United States, and Asia, according to Wolf's office.

Patch file photo.